Stocks
G1 Therapeutics (GTHX) EV/EBITDA US GAAP (year values) |
||||||||
| FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | LTM ? | |||
| EV/EBITDA | ? | -5.26 | -2.04 | 0.45 | 0.73 | -10.8 | ||
| Changes by years, y/y, % | -61% | -122% | +61% | |||||
G1 Therapeutics. EV/EBITDA
G1 Therapeutics. EV/EBITDA, changes, %
G1 Therapeutics (GTHX) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2023Q2 | FY2023Q3 | FY2023Q4 | FY2024Q1 | FY2024Q2 | LTM ? | |||
| EV/EBITDA | ? | -1.28 | 1.58 | 0.73 | 1.01 | 0.38 | -10.8 | |
| Changes by years, y/y, % | +39% | -146% | +61% | -513% | -130% | |||
| Changes by quarters, q/q, % | +426% | -224% | -54% | +38% | -62% | |||
